Skip to main content
Arbutus Biopharma Corp logo

Arbutus Biopharma Corp — Investor Relations & Filings

Ticker · ABUS ISIN · CA03879J1003 US Manufacturing
Open in API
Filings indexed 1,013 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country US United States of America
Listing US ABUS

About Arbutus Biopharma Corp

https://www.arbutusbio.com/

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company focused on developing therapeutics for viral diseases, with a primary emphasis on creating a functional cure for chronic Hepatitis B virus (cHBV) infection. The company's strategy involves developing combination regimens that utilize multiple agents with complementary mechanisms of action. This approach aims to suppress viral replication, reduce viral antigens, and reawaken the host's immune response. A key candidate in its pipeline is imdusiran, an RNA interference (RNAi) therapeutic. Arbutus leverages its expertise in virology and drug delivery systems to advance its portfolio of clinical assets for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes Item 2.02, which announces the results of operations and financial condition for the third quarter ended September 30, 2025, and references a press release (Exhibit 99.1) containing the financial results. It also includes Item 8.01 about posting an updated corporate presentation (Exhibit 99.2). The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of a press release and a presentation. The document length is 3639 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document is classified as a Regulatory Filing (RNS) because it is a current report announcing events and referencing other documents rather than containing the full financial report itself.
2025-11-13 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content includes an announcement about abstracts accepted for presentation at a medical conference and a press release attached as an exhibit. There are no financial statements or detailed financial data included. The document is relatively short (3530 characters) and primarily serves as an announcement of an event and a press release. Therefore, it is not an Annual Report, Earnings Release, or other detailed financial report. It fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2025-10-07 English
FORM 8-K
Legal Proceedings Report Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated September 9, 2025. It reports a legal event: a claim construction ruling in a patent infringement lawsuit involving Arbutus Biopharma Corporation and Pfizer/BioNTech. The document includes a description of the court order and opinion as an exhibit. There are no financial statements or detailed financial data presented. The primary content is an update on legal proceedings. According to the filing definitions, updates on significant lawsuits or regulatory actions fall under Legal Proceedings Report (LTR). The document length is 3794 characters, which is relatively short but contains substantive information about the legal matter, not just an announcement or a certification. Therefore, the appropriate classification is Legal Proceedings Report (LTR).
2025-09-10 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-13 English
FORM 4
Director's Dealing
2025-08-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.